News Search Results
Mar 05, 2026, 06:00 ET Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Mar 05, 2026, 01:15 ET New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: F. Hoffman-La Roche AG
Mar 04, 2026, 20:40 ET 以千分之一劑量 CAR-T 實現血液瘤與紅斑狼瘡100%完全緩解，晶泰孵化企業萊芒生物完成近2億元融資，「平價」新型高效細胞療法開啟臨床轉化
Ltd）是一家處於臨床階段的免疫代謝創新藥物研發公司，由瑞士洛桑聯邦理工學院（EPFL）唐力教授團隊聯合晶泰科技共同創立。基於免疫代謝重編程（META 10）+前沿人工智能（AI）的創新技術，公司專注於研發代謝增強型腫瘤免疫治療藥物。公司核心技術 META 10 展示出治癒實體腫瘤的巨大潛力，相關成果發表於 Nature、Nature Biotechnology、Nature Immunology 和 Lancet Haematology 等國際頂級學術期刊，並申請了多項 PCT 專利和中國發明專利。2022 年以來，公司累計獲得超 4 億元風險投資和項目資助，榮膺 2025 年全國 「顛覆性技術創新」 大賽最高獎項等數十項生物醫藥領域國家或省市級獎項，併入選國家重點研發計劃「顛覆性技術創新」
More news about: 晶泰科技
Mar 04, 2026, 18:01 ET Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight
This has accelerated its adoption in oncology, immunotherapy, and gene therapy.Increased R&D Investment: Pharmaceutical and biotechnology companies, along with academic institutions, are substantially investing in research to develop next-generation nanotherapeutics and nano-diagnostics.Rising
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 16:01 ET AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND
best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic
More news about: Amgen
Mar 04, 2026, 13:00 ET Rice-led research to develop first regenerative therapy for lymphedema receives up to $18.2M federal award
RBL LLC biotechnology startup SteerBio to drive clinical development and commercializationHOUSTON, March 4, 2026 /PRNewswire/ --A team of researchers led by Rice University bioengineer Omid Veiseh
More news about: Rice University
Mar 04, 2026, 10:27 ET Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities
Level 1 certified quality systems, as well as qualification as a Class II Unsealed Radioactive Material Workplace, providing pharmaceutical and biotechnology partners with reliable, audit-ready laboratory services that meet global regulatory standards. Its strong track record includes supporting regulatory
More news about: Frontage Laboratories, Inc.
Mar 04, 2026, 09:11 ET Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
epicenter, while expanding its presence in Europe by establishing the UK Biocentre as a European-wide operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. This major hub will support our already established biorepository in Griesheim, Germany
More news about: Azenta
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
creates more commercial and social values to become a global leading biopharmaceutical enterprise.About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: Akeso, Inc.
Mar 04, 2026, 08:31 ET MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
CAMBRIDGE, Mass., March 4, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer, will participate
More news about: MetaVia Inc.
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
nanoparticles and without the risk of the anti-vector response historically seen with viral vector platforms.About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Mar 04, 2026, 07:05 ET REGENXBIO Announces Presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Interpretation." The event will feature leading experts and take place March 9, 2026 at 12 p.m. ET.ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Mar 04, 2026, 07:00 ET HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting
BOSTON, March 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target natural regulatory pockets, today announced the
More news about: HotSpot Therapeutics
Mar 04, 2026, 07:00 ET Matricelf Ltd. (TASE: MTLF) Reports Positive RNA Sequencing Results Demonstrating Promising Safety Profile of Its Personalized Spinal Cord Implant
prepares for advanced preclinical studies and future human clinical trials.About Matricelf Ltd.Matricelf Ltd. (TASE: MTLF) is a biotechnology company focused on developing personalized autologous regenerative therapies for spinal cord injury. The company's platform integrates stem cell
More news about: Matricelf Ltd.
Mar 03, 2026, 22:49 ET MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology.We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and
More news about: MGI TECH
Mar 03, 2026, 21:56 ET Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
preparedness," said Dr. Rob Burgess, Chief Business Officer at Sino Biological US.About Sino BiologicalSino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and customized research services. Serving researchers in more than 90 countries,
More news about: Sino Biological, Inc.
Mar 03, 2026, 21:00 ET Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
in asymptomatic adults. BMC Medicine, 23(1).About Gene SolutionsGene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging multi-omics, Next-Generation
More news about: Gene Solutions Genomics Pte Ltd
Mar 03, 2026, 20:53 ET Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
preparedness," said Dr. Rob Burgess, Chief Business Officer at Sino Biological US.About Sino BiologicalSino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and customized research services. Serving researchers in more than 90 countries,
More news about: Sino Biological, Inc.
Mar 03, 2026, 16:01 ET Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich
environments worldwide.Established in 1968, analytica is the leading global trade fair for laboratory, technology, analysis, and biotechnology. The 2026 trade show and conference is expected to bring together over 30,000 lab professionals, planners, and industry leaders to explore advances
More news about: Kewaunee Scientific Corporation
Mar 03, 2026, 16:01 ET Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Calif., March 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the fourth quarter and year ended December 31, 2025, including
More news about: Rigel Pharmaceuticals, Inc.
Mar 03, 2026, 14:36 ET Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
2024. The region's growth is supported by increasing awareness of hematologic cancers, strong public healthcare systems, and rising investment in biotechnology and pharmaceutical research. Countries such as Germany, France, and the U.K. are at the forefront of oncology innovation, with numerous ongoing
More news about: Credence Research Inc.
Mar 03, 2026, 12:12 ET Longevity Medical Institute® Opens Federally Licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory in Los Cabos
/PRNewswire/ -- Longevity Medical Institute® today announced the opening of its federally licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory, further expanding what is now one of the most comprehensive regenerative and advanced diagnostic medical campuses in Los Cabos.
More news about: Longevity Medical Institute LLC
Mar 03, 2026, 11:00 ET bitBiome Announces Major Collaboration Agreement in Commercial-Scale Bio-Manufacturing of Food-Grade Ingredient
to advance next generation biomanufacturing solutions designed for global industrial deployment.About bitBiomebitBiome is a biotechnology company unlocking the full potential of our planet's microbes to power the future of the bioeconomy. bitBiome's platform is built on their proprietary
More news about: bitBiome
Mar 03, 2026, 10:02 ET Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
using encapsulated cell-based therapies.Following its recent rebrand from Avant Technologies, Avaí Bio has fully pivoted to biotechnology, concentrating on sourcing, developing, and protecting advanced cellular therapies through strategic joint ventures and licensing agreements. The
More news about: USA News Group
Mar 03, 2026, 09:25 ET Insilico Medicine and Liquid AI Announce Strategic Partnership Delivering Lightweight Scientific Foundation Models for Drug Discovery
liquid.ai.About Insilico Medicine: Insilico Medicine is a clinical-stage biotechnology company using AI for drug development across cancer, fibrosis, immunity, central nervous system diseases, and aging-related conditions. The company's
More news about: Insilico Medicine; Liquid AI